Literature DB >> 3034207

Beta interferon production in primed and unprimed cells infected with human cytomegalovirus.

J E Rodriguez, T R Loepfe, N S Swack.   

Abstract

Human cytomegalovirus induced beta interferon in cultures of human foreskin cells. The inhibitor was first released between 8 and 16 hours after infection, about 48 hours before progeny virus. In cultures infected with low concentrations of virus, interferon was produced as the infection spread, and then in amounts larger than expected. After infection with cytomegalovirus, cells which had been primed for 48 hours with purified beta interferon produced significantly more interferon than unprimed cells, and the interferon was produced earlier, between 2 and 8 hours after infection. CMV-induced interferon also was able to prime cells. The data suggest that the relatively large quantities of interferon detected in cultures infected with low concentrations of cytomegalovirus result from endogenous priming: those cells infected early first produce interferon which primes uninfected cells, then virus which induces the primed cells to produce interferon in relatively high concentrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034207     DOI: 10.1007/BF01310712

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  12 in total

1.  Interferon and cytomegalovirus in vivo and in vitro.

Authors:  L A Glasgow; J B Hanshaw; T C Merigan; J K Petralli
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

2.  Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides.

Authors:  M F Stinski
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

3.  Cytomegalovirus interference in vitro.

Authors:  L A Glasgow
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

4.  Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication.

Authors:  T Furukawa; A Fioretti; S Plotkin
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

5.  Plaque assay of cytomegalovirus strains of human origin.

Authors:  B B Wentworth; L French
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

6.  Effect of interferon on early interferon production.

Authors:  H B Levy; C E Buckler; S Baron
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

7.  Human cytomegalovirus persists in cells treated with interferon. Brief report.

Authors:  J E Rodriguez; T R Loepfe; M F Stinski
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  Effect of interferon treatment on interferon production.

Authors:  R M Friedman
Journal:  J Immunol       Date:  1966-05       Impact factor: 5.422

9.  Interferon production by mouse leukocytes in vitro and in vivo.

Authors:  L A GLASGOW; K HABEL
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

10.  Transcription of the human cytomegalovirus genome in productively infected cells.

Authors:  C C Chua; T H Carter; S St Jeor
Journal:  J Gen Virol       Date:  1981-09       Impact factor: 3.891

View more
  5 in total

1.  The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells.

Authors:  D D Sedmak; S Chaiwiriyakul; D A Knight; W J Waldmann
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response.

Authors:  Davide A Abate; Shinya Watanabe; Edward S Mocarski
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Human Cytomegalovirus Enhances Placental Susceptibility and Replication of Human Immunodeficiency Virus Type 1 (HIV-1), Which May Facilitate In Utero HIV-1 Transmission.

Authors:  Erica L Johnson; Sahithi Boggavarapu; Elan S Johnson; Asim A Lal; Parth Agrawal; Siddhartha Kumar Bhaumik; Kaja Murali-Krishna; Rana Chakraborty
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

4.  Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization.

Authors:  Henrike Reinhard; Vu Thuy Khanh Le; Mats Ohlin; Hartmut Hengel; Mirko Trilling
Journal:  PLoS One       Date:  2011-01-17       Impact factor: 3.240

5.  Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma.

Authors:  Bruno Sainz; Heather L LaMarca; Robert F Garry; Cindy A Morris
Journal:  Virol J       Date:  2005-02-23       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.